|
US5744500A
(en)
*
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
IL118836A
(en)
|
1996-07-11 |
2001-01-11 |
Teva Pharma |
Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan
|
|
AU2002244247B2
(en)
|
2001-03-01 |
2007-12-13 |
Harbor Biosciences, Inc. |
Use of certain steroids for treatment of blood cell deficiencies
|
|
JP2006506445A
(ja)
|
2002-08-28 |
2006-02-23 |
ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド |
治療処置の方法
|
|
AU2003282337B2
(en)
*
|
2002-11-07 |
2009-07-16 |
Technion Research And Development Foundation Ltd. |
Neuroprotective iron chelators and pharmaceutical compositions comprising them
|
|
EP1567152B1
(en)
|
2002-11-15 |
2013-08-14 |
Teva Pharmaceutical Industries Limited |
Use of rasagiline with riluzole to treat amyotrophic lateral sclerosis
|
|
US8097608B2
(en)
*
|
2003-11-25 |
2012-01-17 |
Technion Research And Development Foundation Ltd. |
Methods for treatment of cardiovascular disorders and diseases
|
|
EP1686973A4
(en)
*
|
2003-11-25 |
2009-03-25 |
Technion Res & Dev Foundation |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISEASES
|
|
JP2005232148A
(ja)
*
|
2004-02-03 |
2005-09-02 |
Technion Research & Development Foundation Ltd |
神経保護剤としてプロパルギルアミンの使用
|
|
EP1778196A4
(en)
*
|
2004-07-26 |
2008-12-17 |
Teva Pharma |
PHARMACEUTICAL DOSAGES CONTAINING RASAGILINE
|
|
US20060025446A1
(en)
*
|
2004-07-27 |
2006-02-02 |
Jeffrey Sterling |
Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders
|
|
CA2582231A1
(en)
|
2004-09-29 |
2006-10-19 |
Hollis-Eden Pharmaceuticals, Inc. |
Steroid analogs and uses
|
|
HRP20130622T1
(en)
*
|
2005-02-17 |
2013-08-31 |
Teva Pharmaceutical Industries Ltd. |
Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
|
|
CA2901244A1
(en)
|
2005-02-23 |
2006-08-31 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations of improved content uniformity
|
|
US8263655B2
(en)
|
2005-10-06 |
2012-09-11 |
Technion Research And Development Foundation Ltd |
Methods for treatment of renal failure
|
|
JP2009521402A
(ja)
|
2005-11-17 |
2009-06-04 |
テバ ファーマシューティカル インダストリーズ リミティド |
プロパルギル化アミノインダンの分離のための方法
|
|
US7572834B1
(en)
|
2005-12-06 |
2009-08-11 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations and processes for their preparation
|
|
CN103142570A
(zh)
|
2005-12-09 |
2013-06-12 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
低剂量Ladostigil 用于神经保护的用途
|
|
EP1991214B1
(en)
|
2006-02-21 |
2015-08-05 |
Teva Pharmaceutical Industries, Ltd. |
Use of rasagiline for the treatment of multiple system atrophy
|
|
TW200744576A
(en)
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|
|
EP2007369A4
(en)
|
2006-04-03 |
2009-07-01 |
Teva Pharma |
USE OF RASAGILINE FOR THE TREATMENT OF LEG SYNDROME WITHOUT REST
|
|
EP1892233A1
(de)
*
|
2006-08-18 |
2008-02-27 |
Ratiopharm GmbH |
Neue Salze des Wirkstoffs Rasagilin
|
|
RS52183B
(sr)
*
|
2006-12-14 |
2012-10-31 |
Teva Pharmaceutical Industries, Ltd. |
Kristalna čvrsta baza razagilina
|
|
BRPI0718339A2
(pt)
*
|
2006-12-14 |
2014-02-18 |
Teva Pharma |
Composto, composição, composição farmacêutica e processo de fabricação de tanato de rasagilina
|
|
EP1987816A1
(de)
*
|
2007-04-30 |
2008-11-05 |
Ratiopharm GmbH |
Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff
|
|
WO2009032273A1
(en)
*
|
2007-09-05 |
2009-03-12 |
Teva Pharmaceutical Industries, Ltd. |
Method of treating glaucoma using rasagiline
|
|
US8188149B2
(en)
*
|
2007-09-17 |
2012-05-29 |
Teva Pharmaceutical Industries, Ltd. |
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
|
|
WO2009089049A1
(en)
*
|
2008-01-11 |
2009-07-16 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations, their preparation and use
|
|
US20110027354A1
(en)
*
|
2008-04-01 |
2011-02-03 |
Kim Hyoung-Chun |
Anti-parkinsonian compounds
|
|
US20100008983A1
(en)
*
|
2008-06-10 |
2010-01-14 |
Muhammad Safadi |
Rasagiline soft gelatin capsules
|
|
BRPI0909894A2
(pt)
*
|
2008-06-13 |
2015-07-28 |
Teva Pharma |
"método de redução da velocidade de progressão de mal de parkinson em um paciente com mal de parkinson em estágio inicial, método de redução da velocidade de progressão de mal de parkinson, método de atraso da necessidade de terapia antiparkinsoniana sintomática em um paciente de mal de parkinson em estágio inicial, método de redução do risco de um paciente com mal de parkinson que necessita de terapia antiparkinsoniana, método de redução do declínio funcional de um paciente com mal de parkinson em estágio inicial, método de redução do declínio funcional em um paciente com mal de parkinson, método de tratamento de um paciente que exibe sinais iniciais de mal de parkinson, método de redução da fadiga em um paciente com mal de parkinson em estágio inicial, método de redução da velocidade de progressão clínica e tratamento de sintomas de mal de parkinson em um paciente com mal de parkinson, rasagilina ou um sal farmaceuticamente aceitável de rasagilina, composição farmacêutica.
|
|
CA2727021A1
(en)
*
|
2008-06-19 |
2009-12-23 |
Teva Pharmaceutical Industries Ltd. |
Process for purifying rasagiline base
|
|
BRPI0909997A2
(pt)
|
2008-06-19 |
2015-10-27 |
Teva Pharma |
r(+)-n-propargil-1-aminoindano cristalino, composição farmacêutica, processo de secagem de r(+)-n-propargil-1-aminoindano sólido, processo de preparação de uma composição farmacêutica, processo de produção de um lote validado de um produto de farmaco que contém r(+)-n-propargil-1-aminoindano cristalino e pelo menos um veículo farmaceuticamente aceitável para distribuição e processo de prudução de r(+)-n-propargil-1-aminoindano cristalino
|
|
US20100189791A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Teva Pharmaceutical Industries, Ltd. |
Delayed release rasagiline malate formulation
|
|
DK2451771T3
(da)
|
2009-07-09 |
2014-09-08 |
Ratiopharm Gmbh |
Salte af rasagilin og farmaceutiske fremstillingsmåder heraf
|
|
CN102791258B
(zh)
|
2010-02-03 |
2018-05-08 |
图必制药公司 |
雷沙吉兰的延长释放制剂及其用途
|
|
WO2012015946A1
(en)
|
2010-07-27 |
2012-02-02 |
Teva Pharmaceutical Industries Ltd. |
Dispersion of rasagiline citrate
|
|
RU2587330C2
(ru)
|
2010-07-27 |
2016-06-20 |
Тева Фармасьютикал Индастриз Лтд. |
Применение разагилина для лечения обонятельной дисфункции
|
|
HK1200314A1
(en)
|
2011-10-10 |
2015-08-07 |
Teva Pharmaceuticals Usa, Inc. |
R(+)-n-methyl-propargyl-aminoindan
|
|
HK1200315A1
(en)
|
2011-10-10 |
2015-08-07 |
Teva Pharmaceutical Industries Ltd. |
R(+)-n-formyl-propargyl-aminoindan
|
|
US9308182B2
(en)
|
2012-08-17 |
2016-04-12 |
Teva Pharmaceutical Industries, Ltd. |
Parenteral formulations of rasagiline
|
|
CN104177610A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN104177611A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN111333517A
(zh)
*
|
2018-12-19 |
2020-06-26 |
上海奥博生物医药技术有限公司 |
一种制备雷沙吉兰的改进方法
|